|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Mild Cognitive Impairment | |||||
| Alzheimer's Disease | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Alzheimer Disease | |||||
| 3 | More general conditions related to this trial | ||||
| Brain Diseases | |||||
| Central Nervous System Diseases | |||||
| Delirium, Dementia, Amnestic, Cognitive Disorders | |||||
| Dementia | |||||
| Mental Disorders | |||||
| Nervous System Diseases | |||||
| Neurodegenerative Diseases | |||||
| Tauopathies | |||||
| 4 | Interventions listed in this trial | ||||
| Mail and Live Phone | |||||
| Interactive Voice Response (IVR) | |||||
| Home-based Computer Kiosk | |||||
| Traditional Evaluation Instruments | |||||
| 5 | Sponsors listed in this trial | ||||
| National Institute on Aging (NIA) | |||||
| Alzheimer's Disease Cooperative Study (ADCS) | |||||